Methotrexate therapy for juvenile rheumatoid arthritis
β Scribed by Brian M. Feldman; Earl D. Silverman
- Book ID
- 117163471
- Publisher
- Elsevier Science
- Year
- 1991
- Tongue
- English
- Weight
- 109 KB
- Volume
- 118
- Category
- Article
- ISSN
- 1097-6833
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Children with juvenile rheumatoid arthritis (JRA) have been reported to require higher doses (per kg body weight) of methotrexate (MTX) than adults with rheumatoid arthritis to control their disease. The purpose of the present study was to characterise the plasma pharmacokinetics of MTX and its majo
Nineteen selected patients with severe, mostly systemic onset, juvenile rheumatoid arthritis were treated with methotrexate (MTX) for an average of 10.5 months. Twelve patients showed statistically significant improvement, as measured by the number of affected, swollen, tender, and functionally impa